Ignite Creation Date:
2025-12-25 @ 2:08 AM
Ignite Modification Date:
2025-12-26 @ 4:29 PM
Study NCT ID:
NCT05769660
Status:
RECRUITING
Last Update Posted:
2025-03-10
First Post:
2023-02-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate Safety and Efficacy of BEY1107 in Combination with Temozolomide in Patients with Recurrent or Progressive Glioblastoma Multiforme (GBM)
Sponsor:
BeyondBio Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-11-29
Start Date Type:
ACTUAL
Primary Completion Date:
2026-11-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2023-02-05
First Submit QC Date:
None
Study First Post Date:
2023-03-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-03-06
Last Update Post Date:
2025-03-10
Last Update Post Date Type:
ACTUAL